AzTrials
AzTrials

Pain(ISB)-(ITM)NCT07016386

Ultrasound-guided Interscalene Block Versus Infraspinatus-Teres Minor Plane Block in Shoulder Arthroscopy

A study testing Group A: will receive an ultrasound-guided interscalene block (ISB) and Group B:will receive an ultrasound-guided infraspinatus-teres minor (ITM) interfacial plane block in people with Pain and Pain Management, run by Misr University for Science and Technology at 1 site in Egypt.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

This study aims to compare the efficacy and safety of ultrasound-guided Interscalene block (ISB) versus Infraspinatus-Teres minor (ITM) interfacial plane block in shoulder arthroscopic surgery. A prospective, randomized clinical trial will be conducted with 46 patients. Read more about this study

Who is it for?
Ages 20 to 60 yearsHealthy volunteers can take part
What is being tested?
Group A: will receive an ultrasound-guided interscalene block (ISB) and Group B:will receive an ultrasound-guided infraspinatus-teres minor (ITM) interfacial plane block
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
46 participants
Where
1 siteEgypt
Study dates
15 Jun 2025to 31 Jan 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Patients aged 20 to 60,
  • ASA classification I or II,
  • scheduled for arthroscopic shoulder surgery,
  • will be randomized 1:1 into two groups before the induction of general anesthesia (GA)

Who cannot join

  • Patients who refuse participation.
  • Have allergies to local anesthetics.
  • Phrenic nerve dysfunction.
  • Chronic opioid use.
  • ASA III or higher classification.
  • Coagulopathy.
  • Severe chronic obstructive pulmonary disease.
  • Local infection at the injection site

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Souad Kafafi University Hospital (SKUH), Faculty of medicine, Misr University for Science and Technology (MUST)

    Giza, Giza Governorate, 15525

Other trials in Egypt

About this study

Official title: Ultrasound-guided Interscalene Block (ISB) Versus Infraspinatus-Teres Minor (ITM) Interfacial Plane Block in Shoulder Arthroscopic Surgery

This study aims to compare the efficacy and safety of ultrasound-guided Interscalene block (ISB) versus Infraspinatus-Teres minor (ITM) interfacial plane block in shoulder arthroscopic surgery.

A prospective, randomized clinical trial will be conducted with 46 patients. Approval was obtained from the Medical Ethics Committee (2022/0126), and written informed consent will be collected from all participants. Patients aged 20-70, ASA I-II, scheduled for arthroscopic shoulder surgery will be divided before the induction of general anesthesia (GA) into two groups:

Read more

Group A: will receive the ultrasound guided ISB technique with a 15ml solution of 7.5ml lidocaine 2% and 7.5ml bupivacaine 0.5% be injected between the anterior and middle scalene muscles.

Group B: will receive the ultrasound guided ITM block with the same anesthetic solution be injected between the infraspinatus and teres minor muscles.

Researchers will examine the following outcomes;

  1. Primary outcome measure: Efficacy of analgesia by Pain score; will be measured by Numerical Rating Scale (NRS) score (0=no pain,1-3=mild,4-6=moderate,7-9=sever,10=most sever) at postoperative 12 hour.
  2. Secondary outcome measures:
  3. Duration of analgesia, starting from recovery from general anesthesia (GA) to 1st time giving the patient rescue analgesia ( measured by NRS pain score at 0, 6 ,12, 18 and 24 postoperative hours)
  4. Risk of complications from techniques
  5. Patient satisfaction after surgery.
  6. Rescue analgesic consumption
  7. Hemodynamics monitoring; measurements of heart rate and mean arterial blood pressure before induction of anesthesia and every 15 minutes during surgery till end of surgery
Read the detailed description
  1. Study design:

Randomized comparative study.

II. Study setting and location:

The study will be conducted at the operative room of Souad Kafafi University Hospital (SKUH), Misr University of science and Technology (MUST).

III. Study population:

Patients aged from 20 to 60 years old scheduled for shoulder surgery will be randomized in a 1:1 ratio after induction of general anesthesia (GA) to either: Group A: Received the ultrasound guided ISB technique with a 15ml solution of 7.5ml lidocaine 2% and 7.5ml bupivacaine 0.5% injected between the anterior and middle scalene muscles.

Group B: Received the ultrasound guided ITM block with the same anesthetic solution injected between the infraspinatus and teres minor muscles.

IV. Study procedures:

  1. Randomization Patients will be randomly allocated by a computer-generated table into one of the study groups; the randomization sequence will be concealed in sealed opaque envelopes.
  2. Study protocol
  • All Patients will have a pre-operative assessment visit, which will include; history taking, complete physical examination and review of all the results of the routine investigations (CBC, Coagulation profile, renal functions, liver functions).
  • On Arrival to the preparation room, they will receive the following premedication via intravenous (IV) route: Midazolam 0.03 mg/kg, Ondansetron 4 mg and Omeprazole 40 mg iv infusion.
  • Upon Arrival to the operating room, standard monitoring will be applied which include: Pulse Oximeter, Noninvasive Blood Pressure and Six-lead electrocardiogram (ECG).
  • General anesthesia will be induced using: Propofol 1-2mg/kg, Fentanyl1-2 μg/kg, Morphine 0.1mg/kg and Atracurium 0.5 mg/kg.
  • After endotracheal intubation, side way capnography will be applied to measure end tidal CO2 pressure in the expired air.
  • General anesthesia will be maintained using Sevoflurane 1-2 MAC (Mean Alveolar Concentrations) in O2/ Air 50% / 50%, Paracetamol 1gm iv infusion, ketorolac 30 mg iv and incremental doses of Atracurium 0.1mg/kg/30 minutes.

The patients will be randomly allocated into two groups:

Group A:

Ultrasound-guided Interscalene block (ISB) technique.

Group B:

Ultrasound-guided Infraspinatus-teres minor (ITM) interfacial plane block technique

  1. Study outcomes:
  2. Primary outcome measure:
  • Efficacy of analgesia by Pain score; will be measured by Numerical Rating Scale (NRS) score (0-10; 0=no pain,1-3=mild,4-6=moderate,7-9=sever,10=most sever) at postoperative12 hours.
  1. Secondary outcome measures:
  2. Duration of analgesia, starting from recovery from general anesthesia (GA) to 1st time giving the patient rescue analgesia ( measured by NRS pain score at 0, 6 ,12, 18 and 24 postoperative hours).
  3. Risk of complications from techniques.
  4. Patient satisfaction after surgery
  5. Total intraoperative analgesia dose (fentanyl consumption) and total postoperative analgesia dose (morphine consumption).
  6. Hemodynamics monitoring; measurements of heart rate and mean arterial blood pressure before induction of anesthesia and every 15 minutes during surgery till end of surgery

VII. Statistical analysis:

  1. Sample size: Sample size calculation was based on pain score after Interscalene block (ISB) in shoulder surgery versus other methods retrieved from previous research (Singelyn et al., 2004) (15). Using G power program version 3.1.9.4 to calculate sample size based on effect size of 0.897 (35 ± 25) versus (13±24), using 2-tailed test, α error =0.05 and power = 80.0%, the total calculated sample size will be 21 in each group at least and by adding 10% to compensate for possible drop out then total sample size per group is 23 cases at least.
  2. Statistical analysis:

Data will be analyzed using SPSS (statistical package for social sciences) version 22. Quantitative data will be tested for normality by Kolmogrov-Smironv test then described as mean and standard deviation for normally distributed data, and median and range for non-normally distributed, Qualitative data will be presented as number and percent. The appropriate statistical test will be applied according to data type with the following suggested tests: Student t test and Mann Whitney U test for continuous variables, Chi-Square test for categorical variable.

Being tested
Group A: will receive an ultrasound-guided interscalene block (ISB), Group B:will receive an ultrasound-guided infraspinatus-teres minor (ITM) interfacial plane block
Keywords
Ultrasound guided,, interscaline block,, versus infraspinatus-teres minor block, shoulder arthroscopy.
Medical subject headings
Pain, Agnosia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Group A: will receive an ultrasound-guided interscalene block (ISB)Procedure or surgery

    Group A: will receive an ultrasound-guided interscalene block (ISB) using a 15ml mixture of lidocaine (7.5ml 2%) and bupivacaine (7.5ml 0.5%).

  • Group B:will receive an ultrasound-guided infraspinatus-teres minor (ITM) interfacial plane blockProcedure or surgery

    Group B:will receive an ultrasound-guided infraspinatus-teres minor (ITM) interfacial plane block using a 15ml mixture of lidocaine (7.5ml 2%) and bupivacaine (7.5ml 0.5%).

Study groups in NCT07016386
Study groupRoleWhat they receive
Group A : Ultrasound guided Interscalene block (ISB) techniqueActive comparatorInterscalene block (ISB) technique, patients will be place in the supine position and the patient's head facing away from the side to be blocked. The Ultrasound probe will be applied in sterile fashion on the supraclavicular fossa to find the brachial plexus division lateral to the subclavian artery. Then, the probe will be traced cephalad to the C5-C6 root and interscalene muscles at the level of the cricoid cartilage
Receives: Procedure: Group A: will receive an ultrasound-guided interscalene block (ISB)
Group B: Ultrasound guided Infraspinatus-teres minor (ITM) interfacial plane block techniqueExperimentalInfraspinatus-teres minor (ITM) interfacial plane block technique, Patients will be placed in the lateral position, and a pillow will be wedged under the anterior shoulder and upper arm. The Ultrasound probe will be applied in sterile fashion and put angled obliquely, to be perpendicular to the direction of muscles to obtain the transverse scan of muscles for the ITM block. After palpation of the posterolateral corner of the acromion, the muscle-tendon units of infraspinatus (IS) and teres minor (Tm) on the humeral head will be identified below the corner. At this time, the probe will be moved slightly caudad to identify the borders of Tm. Once the IS and Tm on the humeral head area identified, by moving the probe medio caudally, the interfascial structure of the IS and Tm could be traced on the posterior surface area of the neck of the scapula.
Receives: Procedure: Group B:will receive an ultrasound-guided infraspinatus-teres minor (ITM) interfacial plane block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Efficacy of analgesia

    Will be measured by pain score at 12 hours postoperatively using the Numerical Rating Scale (NRS) (0-10; with 0 means no pain and 10 means most intolerable pain)

    Measured: at 12 hours postoperatively

Secondary outcomes (7)
  1. Duration of analgesia

    duration of analgesia measured by Pain score at 0, 6, 12, 18, and 24 hours postoperatively using the Numerical Rating Scale (NRS) 0-10 with 0 means no pain and 10 means most intolerable pain.

    Measured: Starting from recovery from general anesthesia (GA) to 1st time giving the patient rescue analgesia,

  2. Hemodynamics (heart rate)

    measurements of heart rate (beat per minute)

    Measured: before induction of anesthesia and every 15 minutes during surgery till end of surgery

  3. Total intraoperative analgesic consumption (fentanyl).

    Need and consumption of fentanyl intraoperatively (ug),

    Measured: During surgery; from induction of anesthesia to end of surgery.

  4. Patient satisfaction

    very unsatisfied, unsatisfied, neutral, satisfied, very satisfied

    Measured: for the first postoperative 24 hours

  5. Complications of the techniques

    Local anesthetics toxicity, pneumothorax, phrenic nerve palsy, hematoma formation

    Measured: From time of injection to the end of first 24 hours postoperative

  6. Total postoperative morphine consumption (mg)

    Time to 1st request of rescue analgesia and total dose of postoperative morphine consumption in the studied groups for 24 hours (mg)

    Measured: From recovery from general anesthesia to end of 24hours postoperatively

  7. Hemodynamics; mean arterial blood pressure (mmHg)

    Measurement of mean arterial blood pressure (mmHg)

    Measured: Before induction of anesthesia and every 15 minutes during surgery till end of surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jun 2025
  2. Study start15 Jun 2025
  3. Primary completion20 Jan 2026 (estimated)
  4. Study completion31 Jan 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
46 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07016386
Sponsor's protocol ID
2022/0126
Acronym
(ISB)-(ITM)
Status last verified
Jul 2025
First submitted
24 May 2025
Last updated
23 Jul 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Demographic Information: Age, sex, race, and other relevant demographic details. Baseline Characteristics: Health status, medical history, and any pre-existing conditions prior to the trial. Treatment Assignment: Information on the intervention or treatment each participant received. Outcome Measures: Data on primary and secondary outcomes as defined in the trial protocol. Adverse Events: Reports of any side effects or adverse events experienced by participants during the trial. Follow-up Data: Information collected during follow-up periods, including long-term outcomes.

Publications

  • Hewson DW, Oldman M, Bedforth NM. Regional anaesthesia for shoulder surgery. BJA Educ. 2019 Apr;19(4):98-104. doi: 10.1016/j.bjae.2018.12.004. Epub 2019 Feb 6. No abstract available.

    PubMed 33456877

Questions about this trial

What is this clinical trial studying?

A study testing Group A: will receive an ultrasound-guided interscalene block (ISB) and Group B:will receive an ultrasound-guided infraspinatus-teres minor (ITM) interfacial plane block in people with Pain and Pain Management, run by Misr University for Science and Technology at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 23 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Efficacy of analgesia (time frame: at 12 hours postoperatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07016386, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jul 2025; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in